Get the latest tech news
FDA approves first implant to treat rheumatoid arthritis | It's a potentially life-changing technology that can zap pain by delivering one-minute electrical pulses to the vagus nerve – a key neural pathway that regulates inflammation.
The first-ever neuroimmune modulation implant has been approved for people with moderate to severe rheumatoid arthritis (RA) who haven't found relief with traditional medications. It's a potentially life-changing technology that can zap pain by delivering one-minute electrical pulses to the vagus…
While there's no cure for RA, this implant is a game-changer for sufferers who have struggled with traditional treatments – up to 50% of people on medication stop the drugs within two years, mostly due to diminishing returns or adverse side effects. “The approval of the SetPoint System highlights the potential of neuroimmune modulation as a novel approach for autoimmune disease, by harnessing the body’s neural pathways to combat inflammation,” said Mark Richardson, MD, Director of Functional Neurosurgery at Massachusetts General Hospital, and national surgical principal investigator in the RESET-RA study. “After implantation during a minimally invasive outpatient procedure, the SetPoint device is programmed to automatically administer therapy on a predetermined schedule for up to 10 years, simplifying care for people living with RA.”
Or read this on r/tech
